All News

From funding innovative research to advocating for government action to providing a support structure for our community, no other organization does more to fight type 1 diabetes (T1D) than JDRF.

Patients with Parkinson disease were found to be more likely to experience vision and eye issues, such as blurry vision, dry eyes, trouble with depth perception, and problems adjusting to rapid changes in light, compared with people without the disorder, according to study findings.

In 11 patients with severe cases of COPD and hypercapnic respiratory failure, lung volume reduction coil treatment was associated with significant decreases in carbon dioxide levels and improvement in quality-of-life and respiratory function tests, according to study findings.

Today CMS announced the Part D Senior Savings Model, allowing Medicare Part D prescription drug plans to offer plan choices that provide a range of insulins to beneficiaries, at a maximum $35 copay per 30-day supply throughout the benefit year.

In children and adolescents with sickle cell disease, those who lacked ample vitamin D were hospitalized more often, had longer hospital stays, and made more frequent visits to the emergency department, according to study findings.

Racial and ethnic biases held by research and clinical professionals could contribute to low minority participation in oncology clinical trials, according to a study recently published in Cancer, a journal from the American Cancer Society.

Johnson & Johnson and Apple’s Heartline trial is serving as a model of success for virtual clinical trials; from 2012 to 2018, conscientious vaccine exemption rates rose in Texas schools; a 25% increase in emergency department visits in just 2 years from patient self-harm shows the importance of suicide prevention.

Researchers were able to use questionnaire responses to accurately determine natural clusters of chronic migraine phenotypes, according to a study published in Scientific Reports.

New federal regulations will allow patients to download their electronic health records (EHRs) and other healthcare data onto their smartphone; FDA's final report on the link between talc, asbestos in cosmetic products finds 43 negative, 9 positive results; 2 proposed bills aim to support mental health legislature in Minnesota schools.

Research has suggested patients with psoriasis are at a higher risk of hypertension, but a recent meta-analysis aimed to prove the case by looking at tens of thousands of cases.

A second individual may have been cured of HIV following an allogeneic stem-cell transplant for stage 4b refractory Hodgkin lymphoma with Δ32-mutated cells, which are resistant to the virus. These cells did not express the CCR5 chemokine receptor, 1 of 2 methods of entry for HIV into a host cell.

The rules seek to end information blocking and give patients more control and choice over their data.

Utilizing the latest information provided by the World Health Organization and CDC on the novel coronavirus, COVID-19, the American Academy of Ophthalmology issued a set of guidelines recommending protection for the mouth, nose, and eyes when caring for patients potentially infected with the virus.

The FDA announced a new draft guidance to consider broader evaluations beyond cardiovascular outcomes trials for type 2 diabetes (T2D) medications.

Fatigue profiles for patients with multiple sclerosis (MS) are based on severity of fatigue and not on various dimensions, according to a study recently published in Scientific Reports.

A year after being only the second person to be cured of HIV, the “London Patient” revealed his identity; BMS announced today that its combination therapy for multiple myeloma—elotuzumab, lenalidomide, and dexamethasone—failed its primary endpoint of progression-free survival in its phase 3 ELOQUENT-1 trial; Biocon and Mylan N.V. announced that the FDA accepted their biologics license application (BLA) for MYL-14020, a proposed biosimilar to bevacizumab (Avastin), for review.

Patients with relapsing/remitting chronic lymphocytic leukemia (CLL) have a range of new therapeutic options. A new study is the first to directly compare 2 of the more prominent new therapies.

This week’s selection was one of our most-read articles of 2018.

The American Diabetes Association (ADA) recently created a new part of its website, the Engagement Platform, designed to track legislation of interest to consumers.

The combination of the biologic adalimumab and hydroxychloroquine may be responsible for the improvement in lichen planopilaris, including the hair regrowth, according to the study.

The most popular stories of the week on AJMC®.

Eighteen out of 30 studies included in a recent literature review, published in Nutrients, showed a link between serum vitamin D levels and headaches, with the strongest connection established between serum vitamin D and migraine.

Substantial medication and follow-up nonadherence exists among inmates with glaucoma, according to a study published in JAMA Ophthalmology.

Twenty-one people aboard a cruise ship carrying more than 3500 people off the California coast tested positive for the new coronavirus, but only 46 people overall have been tested, and federal officials are trying to bring the ship to a non-commercial port. COVID-19 (which stands for coronavirus disease 2019) passed a global milestone; SARS-CoV-2, the virus that causes the disease, has infected more than 100,000 worldwide.

The authors said their study is the first to show that targeted treaments for patients with certain molecular alterations could be a possibility in pancreatic cancer.

Screening mammography is important for reducing race/ethnicity-associated triple-negative breast cancer disparities among African American and white patients.

This week, the top stories in managed care included a study finding key drug prices are soaring; Congress providing funds for coronavirus; alcohol-related deaths rising.